Selleckchem Inc

Bio Active Compounds.

Recent products

Ebronucimab (Anti-PCSK9)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Ebdarokimab (Anti-IL-12b)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Cergutuzumab (Anti-CEACAM5 / CEA / CD66e)

Price range: £466.00 through £4,152.00 / 652.405,812.80 Standard

Anti-CDH1 / E-cadherin / CD324

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Anti-CD9

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Anti-CD83

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Iladatuzumab (Anti-CD79b)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Dostarlimab (Anti-PDCD1 / PD-1 / CD279)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Grisnilimab (Anti-CD7)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Donanemab (Anti-Amyloid Beta)

Price range: £303.00 through £2,432.00 / 424.203,404.80 Standard

Domvanalimab (Anti-TIGIT)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Anti-CD59

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Gatralimab (Anti-CD52)

Price range: £303.00 through £2,432.00 / 424.203,404.80 Standard

Urabrelimab (Anti-CD47)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Domagrozumab (Anti-GDF8 / Myostatin)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Ligufalimab (Anti-CD47)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

1 667 668 669 705